In short. Melasma is the pattern where treating harder makes it worse. Why rebound darkening happens, what drives it, and why patience is the clinical decision here.
Key points
- Is this pattern melasma, or is it sun-driven pigment?
- What is the risk that treating it will make it darker, and how would that be managed?
- And what maintenance will be needed, since melasma relapses when control lapses?
Melasma is the exception in this subject, and the one pattern where the instinct to treat harder is most likely to cause harm. A face with symmetric, softly edged brown patches across the cheeks, upper lip or forehead does not have a stubborn version of sun damage. It has pigment cells that are already overactive, and treatment that adds heat, inflammation or high energy can leave the skin darker than it started.
What makes melasma different
Sun-driven pigment is a record of exposure, so once exposure stops, the marks fade. Melasma is an active process. Hormonal change is a common trigger, including pregnancy and hormonal contraception, and ultraviolet, visible light and heat all influence it. It is chronic and it relapses, which means the goal is control rather than clearance.
Why rebound happens
The pigment cells involved already produce more pigment than the skin around them, and respond to injury and heat by producing more again. That is the mechanism behind rebound darkening: a pigment-directed light or an aggressive peel injures the skin in order to work, the injury provokes those cells, and the colour that follows is deeper and more diffuse than what was treated. It is a well-recognised outcome, and the strongest argument for treating melasma slowly.
What the approach actually looks like
Protection comes first, and it has to cover visible light and heat as well as ultraviolet, because those are triggers in their own right. Topical agents are then used at a level the skin tolerates, over a long period, one change at a time so a reaction can be attributed. Where a device is considered, it is chosen for being low and slow rather than maximal, and used alongside the topical arrangement.
Questions worth asking before any device is used on facial pigment
Is this pattern melasma, or is it sun-driven pigment? What is the risk that treating it will make it darker, and how would that be managed? And what maintenance will be needed, since melasma relapses when control lapses?
Why patience is the clinical position
Telling someone that a problem will be managed rather than cleared is a harder conversation than offering a course of treatment, and it is the accurate one. Melasma treated gently often improves steadily and stays improved while the arrangement holds. Melasma treated aggressively sometimes improves quickly and then rebounds. The slower route is not a delay before real treatment starts. It is the treatment.
The ceiling, stated plainly
Melasma can be reduced and kept under better control. It cannot be promised to clear, and it cannot be prevented from returning if control lapses. Pregnancy, hormonal contraception, thyroid problems and some medicines all influence it, so those belong in the assessment rather than the background.
Stop and reassess if
- The face is darker than before treatment started, or the darkening has become more diffuse.
- The plan is escalating, with more energy or deeper peeling, after each disappointing result.
- Protection has lapsed, or heat and visible light are not being addressed at all.
Frequently asked questions
How can treatment make melasma worse rather than better?
Because the pigment cells involved are already overactive and respond to injury and heat by producing more pigment. A pigment-directed device or a deep peel injures the skin in order to work, and in melasma that injury can provoke a darker and more diffuse result than the patch that was treated. It is a recognised outcome rather than a rare accident.
Does that mean no treatment at all should be attempted?
It means the approach changes rather than stops. Protection covering visible light and heat, gentle topical agents used over a long period, and any device work chosen for being low and slow rather than maximal. The aim is steady reduction under maintenance, and the arrangement continues because melasma relapses when control lapses.
Why is heat a problem if I am already careful about the sun?
Because melasma responds to warmth as well as to light, so saunas, hot kitchens, prolonged steam and intense exercise in the heat can all contribute even on days when ultraviolet exposure is well managed. That is part of why melasma control is described as an arrangement of daily habits rather than one product applied in the morning.
Risks & Limitations
- Uneven tone is not one condition. Pigment, vessels and texture answer to different treatment, and a plan built on the wrong category can produce no change however long it is continued.
- Pigment that has faded returns with further unprotected sun exposure, and melasma relapses when control lapses. Maintenance is part of the result rather than evidence that treatment failed.
- Melasma is the pattern where aggressive treatment can leave skin darker rather than lighter; rebound darkening after high-energy pigment work is a recognised outcome, not a rare accident.
- No treatment resets skin to a single uniform colour. Tone can be reduced and evened, and pigment held deep in the dermis responds poorly to everything available.
When to Seek Care
- A mole or spot that is changing in size, shape or colour, or that itches, bleeds or fails to heal — have it examined rather than lightened.
- Darkening that has developed over weeks rather than years, or that appeared away from skin exposed to the sun — seek medical assessment.
- Darkening with tiredness, weight change, cold intolerance or dizziness, which may point to a hormonal or metabolic cause.
- Darkening with yellowing of the eyes or skin, dark urine or pale stools — seek medical assessment promptly.
References & Further Reading
- American Academy of Dermatology (AAD) — patient guidance on pigmentation disorders
- International League of Dermatological Societies (ILDS) — global standards of care
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Dermatology Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.